Page last updated: 2024-10-21

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Acid beta-Glucosidase Deficiency

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Acid beta-Glucosidase Deficiency in 1 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Research Excerpts

ExcerptRelevanceReference
"Gaucher disease is an autosomal recessive disease, caused by a lack or functional deficiency of the lysosomal enzyme, glucocerebrosidase (GCase)."1.42Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease. ( Alvarez-Fischer, D; Andreas, H; Hirsch, EC; Höglinger, GU; Höllerhage, M; Lu, L; Noelker, C; Oertel, WH; Roscher, R; Sturn, A; Vulinovic, F, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Noelker, C1
Lu, L1
Höllerhage, M1
Vulinovic, F1
Sturn, A1
Roscher, R1
Höglinger, GU1
Hirsch, EC1
Oertel, WH1
Alvarez-Fischer, D1
Andreas, H1

Other Studies

1 other study available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Acid beta-Glucosidase Deficiency

ArticleYear
Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease.
    Journal of the neurological sciences, 2015, Sep-15, Volume: 356, Issue:1-2

    Topics: 1-Deoxynojirimycin; 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Cell Count; Cells,

2015